NEW YORK, April 14, 2015 /PRNewswire/ -- Methodology
•Primary interviews were conducted with key industry experts and regulatory authorities. Designation of interviewed participants include chief executive officers, marketing managers, directors, and vice presidents.
•Secondary research sources such as the in-house Frost & Sullivan database, Frost & Sullivan's Decision Support Database, company annual reports, scientific journals, and industry-related articles have been utilized.
•The objective of the research service is to present a comprehensive analysis of the contrast auto-injectors market with respect to market potential and key market dynamics.
•The study also covers factors driving the growth, challenges affecting the industry, and opportunities within the total market and the segments as estimated for the forecast period.
•The study period covered is from 2012 to 2018, with the base year of 2013 and the forecast period from 2014 to 2018.
•In 2013, the Western European contrast auto-injectors market was estimated at $ x million, with a unit shipment of x units (combination of new and replacement units).
•Computed tomography (CT) and magnetic resonance imaging (MRI) modality-based auto-injectors accounted for x % of the total market with respect to unit shipments and x % for revenue generation.
•The introduction of new technologies such as roll pump-based auto-injectors, hydraulic powered auto-injectors, syringe-free injectors, and add-on features such as fluid management has produced an aggressive and competitive market.
•Competitive pricing of products and full fledged workflow integration between the imaging systems and injector reporting modules generate strong demand and clientele for auto-injectors in the Western Europe market.
•Manufacturers such as Bayer Healthcare, Ulrich, and Bracco Imaging are major market participants.
•Sales and distribution (S&D) proportion for contrast auto-injectors in West Europe include:
oBundling sales x – %
oStand-alone sales x – %
oReplacement sales x – %
•Countries such as Germany, France, Spain, Turkey, Italy, and the United Kingdom contribute x % of the total contrast auto-injectors market in both revenue and in volume shares for 2013
•A reduction in medical errors caused by the adoption of innovative technologies for auto-injectors, readily available consumables, and preloaded/prefilled syringes with contrast agent/medium have attracted market activity concerning a cost-effective solution for better accuracy, precision, and transfer of information within the hospital.
•An increase in hybrid operating rooms (ORs), state-of-the art radiology divisions in hospitals, and patient-flow have created adequate demand for adopting automated workflow of injectors with integrated imaging modalities.
•Western European countries (e.g., Germany, France, Italy, Spain, and the United Kingdom) have experienced an immense increase in the number of CT and MRI procedures in recent years (2009–2013) scaling to about x – % of the total European imaging market.
•Favorable conditions such as the rising incidence of cancer, sports injuries, cardiac procedures, and ortho-related health issues have increased the number of CT, MRI, and CT-assisted imaging procedures performed.
•Hence, the market for CT and MRI contrast auto-injectors is growing in proportion to the CT and MRI systems market. On the other hand, the market is saturated in a few countries (i.e., Spain, Portugal, Italy) due to unfavorable budget conditions.
•Angiography auto-injectors form an integral part of the cardiac imaging system and can be combined with an injector reporting system, making them interoperable with software that connects the modality for efficient high-quality results and diagnosis.
•Favorable conditions including the rising incidence of cardiac diseases and patient safety concerns about the contrast dosage, in particular among those with renal impairment, began to increase the number of contrast-assisted procedures.
Scope and Segmentation
•The research service covers the contrast auto-injectors market for the following Western European countries: the United Kingdom, Germany, France, Italy, Spain, Belgium, Netherlands, Austria, Portugal, Switzerland, and Turkey.
•This research service provides the following deliverables:
oA quantification of the size and growth forecast of contrast auto-injectors for the above-mentioned markets from 2013 to 2018.
oInsight into the market drivers and restraints, identification of key participants in the markets, and a quantification of company market shares by segment.
oFurther insight into technology trends and opportunities for each of the markets.
Key Questions This Study Will Answer
How is the contrast auto-injector market growing, how long will it continue to grow, and at what rate?
What are the adoption rates for contrast auto-injectors with respect to Western European countries?
How does the demand for quality healthcare services support contrast auto-injectors?
How will the structure of the market change with time? What, if any, are the technology trends? With increasing hospital infrastructure, will the demand for medical imaging equipment increase?
Which segment of the imaging modality continues to provide a better threshold in the market for contrast auto-injectors?
How has the bundling sales structure played a crucial role in sales and distribution of contrast auto-injectors? How has market coverage varied between replacement, stand-alone units, and bundled sales?
Read the full report: http://www.reportlinker.com/p02837200-summary/view-report.html
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: [email protected]
Intl: +1 339-368-6001